AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
It was a pretty bad result overall; while revenues were in line with expectations at US$20m, statutory losses exploded to US$0.64 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. See our latest analysis for AVITA Medical After the latest results, the nine analysts covering AVITA Medical are now predicting revenues of US$105.2m in 2025. If met, this would reflect a substantial 75% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 55% to US$0.99. Before this latest report, the consensus had been expecting revenues of US$101.2m and US$0.96 per share in losses. Overall it looks as though the analysts were a bit mixed on the latest consensus update
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable MarketGlobeNewswire
- AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- miraDry Launches Female Leadership Exchange (FLEX) Initiative: Empowering Women in Medical Technology through Advocacy, Innovation, and Strategic Leadership [Yahoo! Finance]Yahoo! Finance
- AVITA Medical to Present at the Piper Sandler 36?? Annual Healthcare ConferenceGlobeNewswire
RCEL
Earnings
- 11/7/24 - Miss
RCEL
Sec Filings
- 12/5/24 - Form 4
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- RCEL's page on the SEC website